Bryce Richard Paul

See Remarks | Sr VP, Clinical Research &Dev

1 company

Bryce Richard Paul is a See Remarks at PUMA BIOTECHNOLOGY, INC.. Recent SEC Form 4 filings include 0 buys and 10 sells.

Estimated insider holdings value: $978K based on current market prices.

Holdings by Company

PBYIApr 5, 2021

Current Shares121.7K

Value$978.2K

Net Activity-62,888

Bought: 0Sold: 62.9K

Showing 10 filings (page 3)

Date	Ticker	Role	Type	Shares	Price	Value	Chg%
Aug 2, 2019	PBYI Puma Biotechnology, Inc.	See Remarks	Sell	94	$9.00	$846.00	-0.3%
Jul 22, 2019	PBYI Puma Biotechnology, Inc.	See Remarks	Sell	1,841	$10.10	$18,588.76	-4.8%
Jul 2, 2019	PBYI Puma Biotechnology, Inc.	See Remarks	Sell	89	$12.78	$1,137.42	-0.2%
Jun 3, 2019	PBYI Puma Biotechnology, Inc.	See Remarks	Sell	88	$15.07	$1,326.16	-0.2%
May 2, 2019	PBYI Puma Biotechnology, Inc.	See Remarks	Sell	85	$32.38	$2,752.31	-0.2%
Apr 2, 2019	PBYI Puma Biotechnology, Inc.	See Remarks	Sell	88	$35.78	$3,148.65	-0.2%
Mar 4, 2019	PBYI Puma Biotechnology, Inc.	See Remarks	Sell	88	$38.66	$3,402.08	-0.2%
Feb 4, 2019	PBYI Puma Biotechnology, Inc.	See Remarks	Sell	89	$27.77	$2,471.53	-0.3%
Jan 22, 2019	PBYI Puma Biotechnology, Inc.	See Remarks	Sell	1,959	$24.72	$48,426.48	-6.3%
Jan 3, 2019	PBYI Puma Biotechnology, Inc.	See Remarks	Sell	1,210	$20.67	$25,010.70	-3.7%